transparent
micardis_banner

Micardis 8% Reduction composite CV end point

11/01/2022 | Author: Boehringer Ingelheim

ONTARGET  TRIAL: SUPPORTS PROTECTIVE EFFECTS OF MICARDIS® 80 (TELMISARTAN) 80 MG FOR MAJOR CV EVENTS

Document ID: PC-SA-101595 | Expiry Date: 15/05/2026

Related content